...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Clinical utility of mifepristone over oxytocin in preventing adversities of parturition outcomes: a comparative study
【24h】

Clinical utility of mifepristone over oxytocin in preventing adversities of parturition outcomes: a comparative study

机译:米非司酮优于催产素在预防分娩结局逆境中的临床应用:一项比较研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Of the various medical methods of induction, induction with oxytocin and prostaglandins remain the most popular and acceptable methods in modern obstetric practice. The present cross-sectional study conducted in the Department of Obstetrics and Gynecology, Kamla Raja Hospital, Gwalior, mifepristone has been used through oral route for induction of labor. The objectives of the present study were to evaluate the effect of oral mifepristone for induction of labor, to record the outcome of labor and the incidence of operative interference, and to see any adverse effects on mother and/or neonate with its use, to compare its effect with other medical method of labor induction. Methods: The present study is a prospective comparative study carried out in the Department of Obstetrics and Gynecology, G. R. Medical College and Kamla Raja Hospital, Gwalior (M.P.), from May 2009 to June 2010. Total number of patients involved in the study is 119, study group comprised of 69 patients in which oral mifepristone (200mg) was given on day 1 and day 2 of a four-day observation period. The control group comprised of 50 patients induced with intravenous oxytocin group. Results: On overall assessment of the efficacy of labour induction with oral mifepristone as compared to intravenous (I/V) oxytocin, we found that there was no significant difference in the mode of delivery (vaginal and caesarean section) and Apgar score. Conclusions: The induction of active labour induction, induction to delivery interval is higher in mifepristone group as compared to oxytocin group. However, the drug resulted in higher rates of vaginal birth after cesarean section (VBAC) with no grave maternal and fetal outcomes, so thus aspect of oral mifepristone is of great consideration and requires further research.
机译:背景:在各种医学诱导方法中,催产素和前列腺素的诱导仍然是现代产科实践中最流行和可接受的方法。本次横断面研究是通过口服途径使用米非司酮在瓜利奥(Kwalior)的卡姆拉惹医院(Kamla Raja Hospital)的妇产科进行的引产。本研究的目的是评估口服米非司酮引产的效果,记录分娩的结果和手术干扰的发生率,并观察使用米非司酮对母亲和/或新生儿的不利影响,以进行比较其效果与其他医学上引产方法有关。方法:本研究是于2009年5月至2010年6月在GR医学院的妇产科和瓜里拉(MP)的Kamla Raja医院进行的前瞻性比较研究。研究的患者总数为119研究组由69位患者组成,其中在为期4天的观察期的第1天和第2天口服米非司酮(200mg)。对照组包括50例静脉催产素诱导的患者。结果:总体评估口服米非司酮与静脉内(I / V)催产素引产的疗效时,我们发现分娩方式(阴道和剖宫产)和Apgar评分没有显着差异。结论:米非司酮组与催产素组相比,积极分娩诱导,分娩间隔诱导更高。然而,该药物导致剖宫产后的阴道分娩率更高(VBAC),而母体和胎儿的预后均未达到严重水平,因此口服米非司酮具有很大的意义,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号